Skip to Content
Merck
CN

Sterile and Aseptic Sampling

Magnifying glass showing the inside of a bioreactor surrounded by shapes depicting other bioprocess equipment

Sampling plays a pivotal role in pharmaceutical and biopharmaceutical manufacturing by safeguarding the safety and quality of drug products. It ensures product integrity and facilitates ongoing monitoring and control of critical parameters throughout production.

With a variety of sampling technologies and many different types of samples, finding the optimum approach for each step of your process can be a challenge.


Key Challenges of Sampling

Key sampling challenges include:

  • Contamination: Microbial contamination and cross-contamination can compromise product quality and sample integrity.
  • Regulatory Compliance: Stringent regulations necessitate the implementation of robust and validated sampling strategies to meet industry standards and ensure product quality and sample integrity.
  • Sampling Strategies: Selecting the appropriate sampling strategy for various process steps is important but for critical process steps, the right sampling strategy is essential to maintain product quality and safety.

This overview of sterile and aseptic and sampling technologies provides a framework to help you navigate the requirements for effective sampling throughout process development and manufacturing. By understanding your options, you’ll be empowered to make informed decisions, mitigate risks, enhance process control and maintain compliance with regulatory standards.

Discover How Sampling Can Safeguard Your Manufacturing

Symbolic depiction of a (bio-)pharmaceutical process with persons in lab coats working, possibly taking samples

Why and where do I need to sample?

Sampling in drug manufacturing plays a vital role in ensuring quality, safety and efficacy of pharmaceutical and biopharmaceutical products and is mandated by Good Manufacturing Practice (GMP) principles. Analyzing samples helps manufacturers demonstrate that their products meet quality standards, and are safe, effective, and free from contamination.

A robust sampling strategy is an integral part of every stage of development and manufacturing and reinforces the commitment of manufacturers to maintain the highest quality standards. Sampling strategies include starting/raw materials, intermediates and final products.

A person in a lab coat looking at a checklist

Regulatory bodies and industry groups advocate for closed sampling technologies to reduce microbial ingress and ensure representative samples. This approach prioritizes process protection and sample integrity, essential for maintaining high quality and safety standards.

Risk assessments are pivotal in determining the right sampling strategy based on potential impacts to the drug product. Advanced sampling technologies enable accurate assessment of critical parameters, proactive measures to mitigate contamination risks, and continuous monitoring for process control.

Balancing effective bioburden control strategies with regulatory requirements for sampling and testing requires comprehensive risk analysis guided by the recommendations of the International Council for Harmonisation Q9 guideline.

People in lab coats looking at a monitor showing different data sets, possibly analytical results

Sampling has become an essential tool in pharma and biopharma manufacturing for monitoring of critical process parameters (CPPs) and critical quality attributes (CQAs) across all modalities, unit operations, and development stages.

The increasing adoption of process analytical technologies (PAT) highlights the crucial role of sampling in maintaining process control. Automated sampling systems enable near real-time measurements with minimal operator involvement in both process development and GMP manufacturing.

Samples are automatically collected and delivered to at-line, in-line or on-line analytical destinations integrated with PAT tools to monitor CPPs and CQAs, ensuring compliance with stringent biopharmaceutical regulations

A person considering different sampling options (manual and automated) for a (bio-)pharmaceutical process, depicted by holding icons representing each option in their hands

Determining the right sampling strategy with manual or automated sampling systems depends on the process stage, objective of sampling and availability of equipment and funding. A process may exclusively utilize manual sampling or may have evolved to include both manual and automated sampling. Understanding the benefits of the different technologies, will help you understand how each approach can be complementary to help you monitor and control your process.

Closed, sterile manual sampling technologies offer an easy way to confidently sample throughout your process and enable frequent, accurate sampling from multiple access points. Automated, aseptic sampling technologies collect samples from a source without manual intervention and transport them directly for analysis, to at-line or on-line analytical tools.



Related Webinars

On-Demand Webinar: Crucial for Aseptic Processing in Manufacturing Quality and Regulatory Compliance
Closed Sampling: Crucial for Aseptic Processing in Manufacturing Quality and Regulatory Compliance

In this webinar we will explore the regulatory framework that guides sampling methodologies and outline the key qualifications necessary for effective sampling assembly, including system integrity evaluations.

Sign In To Continue

To continue reading please sign in or create an account.

Don't Have An Account?